VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Wednesday, December 31, 2025
Stock Comparison
Abbott Laboratories vs CME Group Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Abbott Laboratories
ABT · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Abbott Laboratories's moat claims, evidence, and risks.
View ABT analysisCME Group Inc.
CME · NASDAQ
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into CME Group Inc.'s moat claims, evidence, and risks.
View CME analysisComparison highlights
- Moat score gap: CME Group Inc. leads (81 / 100 vs 64 / 100 for Abbott Laboratories).
- Segment focus: Abbott Laboratories has 7 segments (26.7% in Cardiovascular & Electrophysiology Devices); CME Group Inc. has 3 segments (81.4% in Trading and Clearing (Derivatives + Cash Markets Platforms)).
- Moat breadth: Abbott Laboratories has 10 moat types across 3 domains; CME Group Inc. has 10 across 5.
Primary market context
Abbott Laboratories
Cardiovascular & Electrophysiology Devices
Cardiovascular, electrophysiology, rhythm management, structural heart and heart failure devices
Global
Hospitals, ambulatory surgery centers, cardiologists/electrophysiologists
Implantable device manufacturer
26.7%
CME Group Inc.
Trading and Clearing (Derivatives + Cash Markets Platforms)
Exchange-traded derivatives (futures and options) trading and central counterparty clearing; plus electronic cash markets matching (U.S. Treasuries/repo, spot FX) tied to CME platforms
Global (core U.S. footprint with international participation)
Institutional and professional traders; commercial hedgers; banks; broker-dealers; futures commission merchants (FCMs); asset managers; proprietary trading firms; governments and central banks
Market operator (exchange/venue) + central counterparty clearing provider
81.4%
Side-by-side metrics
Moat coverage
Shared moat types
Abbott Laboratories strengths
CME Group Inc. strengths
Segment mix
Abbott Laboratories segments
Full profile >Established Pharmaceutical Products
Competitive
Diagnostic Products
Oligopoly
Pediatric Nutrition
Oligopoly
Adult Nutrition
Oligopoly
Diabetes Care (CGM & glucose monitoring)
Duopoly
Cardiovascular & Electrophysiology Devices
Oligopoly
Neuromodulation Devices
Oligopoly
CME Group Inc. segments
Full profile >Trading and Clearing (Derivatives + Cash Markets Platforms)
Oligopoly
Market Data and Information Services
Monopoly
Access, Connectivity and Other Exchange Services
Monopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.